These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25047935)

  • 21. Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors.
    Huang X; Cheng CC; Fischmann TO; Duca JS; Richards M; Tadikonda PK; Reddy PA; Zhao L; Siddiqui MA; Parry D; Davis N; Seghezzi W; Wiswell D; Shipps GW
    Bioorg Med Chem Lett; 2013 May; 23(9):2590-4. PubMed ID: 23535330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties.
    Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and SAR of substituted indoles as selective TrkA inhibitors.
    Hurzy DM; Henze DA; Cabalu TD; Narayan K; Heller A; Cooke AJ
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2695-2701. PubMed ID: 28465100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marine-Derived 2-Aminoimidazolone Alkaloids. Leucettamine B-Related Polyandrocarpamines Inhibit Mammalian and Protozoan DYRK & CLK Kinases.
    Loaëc N; Attanasio E; Villiers B; Durieu E; Tahtouh T; Cam M; Davis RA; Alencar A; Roué M; Bourguet-Kondracki ML; Proksch P; Limanton E; Guiheneuf S; Carreaux F; Bazureau JP; Klautau M; Meijer L
    Mar Drugs; 2017 Oct; 15(10):. PubMed ID: 29039762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity.
    Foloppe N; Fisher LM; Howes R; Kierstan P; Potter A; Robertson AG; Surgenor AE
    J Med Chem; 2005 Jun; 48(13):4332-45. PubMed ID: 15974586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation.
    Du J; Sun H; Xi L; Li J; Yang Y; Liu H; Yao X
    J Comput Chem; 2011 Oct; 32(13):2800-9. PubMed ID: 21717478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel aminothiazole and aminothiadiazole conjugated cyanopyridines as selective CHK1 inhibitors.
    Gomha SM; Abdulla MM; Abou-Seri SM
    Eur J Med Chem; 2015 Mar; 92():459-70. PubMed ID: 25594740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New synthetic route to granulatimide and its structural analogues.
    Yoshida T; Nishiyachi M; Nakashima N; Murase M; Kotani E
    Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):872-6. PubMed ID: 12045354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and structure-activity relationships of soluble 8-substituted 4-(2-chlorophenyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of the Wee1 and Chk1 checkpoint kinases.
    Smaill JB; Lee HH; Palmer BD; Thompson AM; Squire CJ; Baker EN; Booth RJ; Kraker A; Hook K; Denny WA
    Bioorg Med Chem Lett; 2008 Feb; 18(3):929-33. PubMed ID: 18191399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines.
    Burgy G; Tahtouh T; Durieu E; Foll-Josselin B; Limanton E; Meijer L; Carreaux F; Bazureau JP
    Eur J Med Chem; 2013 Apr; 62():728-37. PubMed ID: 23454515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of kinase inhibitors containing a pentafluorosulfanyl moiety.
    Sansook S; Ocasio CA; Day IJ; Tizzard GJ; Coles SJ; Fedorov O; Bennett JM; Elkins JM; Spencer J
    Org Biomol Chem; 2017 Oct; 15(40):8655-8660. PubMed ID: 28984325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: a template-based approach--part 1.
    Dwyer MP; Paruch K; Labroli M; Alvarez C; Keertikar KM; Poker C; Rossman R; Fischmann TO; Duca JS; Madison V; Parry D; Davis N; Seghezzi W; Wiswell D; Guzi TJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):467-70. PubMed ID: 21094608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total synthesis of marine sponge bis(indole) alkaloids of the topsentin class.
    Guinchard X; Vallée Y; Denis JN
    J Org Chem; 2007 May; 72(10):3972-5. PubMed ID: 17444688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and structure based optimization of 2-(4-phenoxybenzoyl)-5-hydroxyindole as a novel CaMKII inhibitor.
    Komiya M; Asano S; Koike N; Koga E; Igarashi J; Nakatani S; Isobe Y
    Bioorg Med Chem; 2012 Dec; 20(23):6840-7. PubMed ID: 23088910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, biological evaluation, and molecular modeling of natural and unnatural flavonoidal alkaloids, inhibitors of kinases.
    Nguyen TB; Lozach O; Surpateanu G; Wang Q; Retailleau P; Iorga BI; Meijer L; Guéritte F
    J Med Chem; 2012 Mar; 55(6):2811-9. PubMed ID: 22352892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and preliminary structure-activity relationship study of 2-aryl-2H-pyrazolo[4,3-c]quinolin-3-ones as potential checkpoint kinase 1 (Chk1) inhibitors.
    Malvacio I; Cuzzolin A; Sturlese M; Vera DMA; Moyano EL; Moro S
    J Enzyme Inhib Med Chem; 2017 Dec; 33(1):171-183. PubMed ID: 29210298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme.
    Sestito S; Nesi G; Daniele S; Martelli A; Digiacomo M; Borghini A; Pietra D; Calderone V; Lapucci A; Falasca M; Parrella P; Notarangelo A; Breschi MC; Macchia M; Martini C; Rapposelli S
    Eur J Med Chem; 2015 Nov; 105():274-88. PubMed ID: 26498573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and in vivo SAR study of indolin-2-one-based multi-targeted inhibitors as potential anticancer agents.
    Zhang L; Zheng Q; Yang Y; Zhou H; Gong X; Zhao S; Fan C
    Eur J Med Chem; 2014 Jul; 82():139-51. PubMed ID: 24904961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibiting NF-κB-inducing kinase (NIK): discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures.
    Li K; McGee LR; Fisher B; Sudom A; Liu J; Rubenstein SM; Anwer MK; Cushing TD; Shin Y; Ayres M; Lee F; Eksterowicz J; Faulder P; Waszkowycz B; Plotnikova O; Farrelly E; Xiao SH; Chen G; Wang Z
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1238-44. PubMed ID: 23374866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved synthesis of isogranulatimide, a G2 checkpoint inhibitor. Syntheses Of didemnimide C, isodidemnimide A, neodidemnimide A, 17-methylgranulatimide, and isogranulatimides A-C.
    Piers E; Britton R; Andersen RJ
    J Org Chem; 2000 Jan; 65(2):530-5. PubMed ID: 10813968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.